Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Angel Yeast Cup Finals and Industry Development Conference Concludes 2025-08-22 18:04
Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore 2025-08-22 09:55
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results 2025-08-21 18:02
SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM 2025-08-21 17:38
Debut of new form of health supplement product! WCC biomedical collaborate with Synmosa toward the niche market! 2025-08-21 09:23
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth 2025-08-21 08:23
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC 2025-08-19 20:09
Nilesh Shah joins Illumina as Head of Region, AMEA 2025-08-19 14:14
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma 2025-08-19 13:26
Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease 2025-08-19 11:00
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries 2025-08-19 08:00
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP). 2025-08-18 21:00
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS 2025-08-18 18:29
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis 2025-08-14 12:02
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration 2025-08-13 09:44
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
Intas & Accord signs Agreement to acquire Prothya Biosolutions 2025-08-11 21:41
Everest Medicines to Announce 2025 Interim Results on August 29, 2025 2025-08-11 17:11
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules 2025-08-11 16:30
HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment 2025-08-11 09:00
1 10 11 12 13 14 263